Home » Topics » Regulatory » Patents

Patents
RSS

Gasherbrum Bio presents new GLP-1 receptor agonists

April 6, 2022

New HBV antiviral compounds patented by Janssen

April 6, 2022

Shaanxi Micot Technology discloses new CaSR agonists

April 6, 2022

Compass Pathfinder synthesizes new safrylamine derivatives

April 5, 2022

J2H Biotech identifies new PROTACs for NSCLC

April 5, 2022

Betta Pharmaceuticals presents new CD73 inhibitors

April 5, 2022

Guangzhou Maxinovel Pharmaceuticals discloses PD-1/PD-L1 interaction inhibitors

April 5, 2022

Chengdu Origiant Pharmaceutical patents RIPK1 inhibitors

April 5, 2022

Shanghai Litedd presents new RET inhibitors

April 4, 2022

Merck & Co. presents new KLKB1 inhibitors

April 4, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...